Germline PALB2 variante patogênica — Parceiro de recrutamento da BRCA2; LOF biallélico produz um...
Visão determinística da entidade fonte YAML. A autoridade clínica permanece com os IDs de fonte citados e estado de assinatura do revisor.
| ID | RF-PAN-PALB2-PARPI-CANDIDATE |
|---|---|
| Tipo | Sinal de alerta |
| Estado | reviewed 2026-04-29 | pending_clinical_signoff |
| Doenças | DIS-BREAST DIS-PDAC DIS-PROSTATE |
| Fontes | SRC-NCCN-BREAST-2025 SRC-NCCN-PANCREATIC-2025 SRC-NCCN-PROSTATE-2025 SRC-PROFOUND-DEBONO-2020 |
Origem da bandeira vermelha
| Definição | Germline PALB2 pathogenic variant — BRCA2's recruitment partner; biallelic LOF produces an HRR-deficient phenotype. Pan-tumor PARPi candidate signal weaker than gBRCA1/2 but emerging. Disease applicability: breast (lifetime risk ~35-55%, NCCN high-penetrance — PARPi off-label / investigational), PDAC (~3-5x baseline risk, POLO label is gBRCA-only but PALB2 frequently grouped clinically), prostate mCRPC (cohort-B in PROfound HRR-non-BRCA/ATM — smaller absolute olaparib benefit but PARPi remains an option per NCCN 2025). Genetic counseling + cascade testing of first-degree relatives required. |
|---|---|
| Direcção clínica | intensificar |
| Categoria | high-risk-biology |
Lógica de Desencadeamento
{
"any_of": [
{
"finding": "palb2_germline",
"value": "pathogenic"
},
{
"finding": "palb2_status",
"value": "pathogenic"
},
{
"finding": "germline_palb2",
"value": "pathogenic"
},
{
"finding": "palb2_pathogenic",
"value": true
}
],
"type": "biomarker"
}
Notas
References BIO-PALB2-GERMLINE. Surveillance recommendations: enhanced breast screening (annual MRI from age 30), pancreatic surveillance per CAPS consortium when family history present. RF distinct from RF-BREAST-BRCA-GERMLINE-ACTIONABLE (BRCA-specific) and RF-PROSTATE-HIGH-RISK-BIOLOGY (which captures HRR pathway broadly via hrr_pathway_mutation key but does not key on palb2_germline directly). No NCCN hereditary-cancer panel source exists in KB — using disease-specific NCCN sources instead; flagged in commit body.
Usado por
Indicação
IND-PROSTATE-MCRPC-2L-CABAZITAXEL- IND-PROSTATE-MCRPC-2L-CABAZITAXELIND-PROSTATE-MCRPC-2L-DOCETAXEL- IND-PROSTATE-MCRPC-2L-DOCETAXEL